Cabotegravir Sodium

3 trials JAnti-infectives

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

3 Sponsors

2 Countries

Phase III

Phase III/IV

Phase IV

Phase III: 1 Phase III/IV: 1 Phase IV: 1

Sponsors using this IMP

Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La C 1 Inserm 1 Inst Medecine Epidemiologie Appliquee 1

All trials

3 total

Impact of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis persistence and coverage in men who have sex with men in Fran… Ended

2024-510678-25-00 Phase III/IV 1 country Inserm
Implementation of Out-of-HOspital administration of the Long-Acting combination cabotegravir+rilpivirine as an optional therapy in HIV-Infec… Ended

2023-503963-41-00 Phase IV 1 country Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocio…
Pilot study, open label, multicenter, evaluating dual antiretroviral therapy with long-acting cabotegravir/lenacapavir IMEA 069 - CALENDULA Ended

2024-516028-33-01 Phase III 1 country Inst Medecine Epidemiologie Appliquee

Showing 1–3 of 3 trials

← All drugs A–Z